{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:11:40Z","timestamp":1791331900706,"version":"4.3.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"31","license":[{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,8,1]]},"DOI":"10.1038\/onc.2012.369","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T13:23:10Z","timestamp":1346073790000},"page":"3587-3597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR\u2013ABL-positive cells"],"prefix":"10.1038","volume":"32","author":[{"given":"N","family":"Chatain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Fahrenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Moriggl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Schmitz-Van de Leur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"M\u00fcller-Newen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,27]]},"reference":[{"key":"BFonc2012369_CR1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia. Blood 2000; 96: 3343\u20133356.","journal-title":"Blood"},{"key":"BFonc2012369_CR2","first-page":"247","volume":"13","author":"K Shuai","year":"1996","unstructured":"Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247\u2013254.","journal-title":"Oncogene"},{"key":"BFonc2012369_CR3","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1182\/blood-2005-09-3596","volume":"107","author":"A Hoelbl","year":"2006","unstructured":"Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, Cui Y et al. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 2006; 107: 4898\u20134906.","journal-title":"Blood"},{"key":"BFonc2012369_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/emmm.201000062","volume":"2","author":"A Hoelbl","year":"2010","unstructured":"Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl MA et al. Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia. EMBO Mol Med 2010; 2: 98\u2013110.","journal-title":"EMBO Mol Med"},{"key":"BFonc2012369_CR5","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1182\/blood-2011-12-397554","volume":"119","author":"C Walz","year":"2012","unstructured":"Walz C, Ahmed W, Lazarides K, Betancur M, Patel N, Hennighausen L et al. Essential role for Stat5a\/b in myeloproliferative neoplasms induced by BCR-ABL1 and Jak2V617F in mice. Blood 2012; 119: 3550\u20133560.","journal-title":"Blood"},{"key":"BFonc2012369_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1039\/b606246f","volume":"2","author":"CP Lim","year":"2006","unstructured":"Lim CP, Cao X . Structure, function, and regulation of STAT proteins. Mol Biosyst 2006; 2: 536\u2013550.","journal-title":"Mol Biosyst"},{"key":"BFonc2012369_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1101\/gad.1643908","volume":"22","author":"L Hennighausen","year":"2008","unstructured":"Hennighausen L, Robinson GW . Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 2008; 22: 711\u2013721.","journal-title":"Genes Dev"},{"key":"BFonc2012369_CR8","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2741\/2274","volume":"12","author":"KD Bunting","year":"2007","unstructured":"Bunting KD . STAT5 signaling in normal and pathologic hematopoiesis. Front Biosci 2007; 12: 2807\u20132820.","journal-title":"Front Biosci"},{"key":"BFonc2012369_CR9","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","volume":"23","author":"CM Silva","year":"2004","unstructured":"Silva CM . Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 2004; 23: 8017\u20138023.","journal-title":"Oncogene"},{"key":"BFonc2012369_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1182\/blood-2006-01-029918","volume":"109","author":"N Harir","year":"2007","unstructured":"Harir N, Pecquet C, Kerenyi M, Sonneck K, Kovacic B, Nyga R et al. Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood 2007; 109: 1678\u20131686.","journal-title":"Blood"},{"key":"BFonc2012369_CR11","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","volume":"107","author":"M Copland","year":"2006","unstructured":"Copland M, Hamilton A, Elrick LJ, Baird JW, Allan EK, Jordanides N et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 2006; 107: 4532\u20134539.","journal-title":"Blood"},{"key":"BFonc2012369_CR12","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1182\/blood-2011-05-355594","volume":"118","author":"JE Cortes","year":"2011","unstructured":"Cortes JE, Kantarjian HM, Brummendorf TH, Kim DW, Turkina AG, Shen ZX et al. Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive CML patients with resistance or intolerance to imatinib. Blood 2011; 118: 4567\u20134576.","journal-title":"Blood"},{"key":"BFonc2012369_CR13","doi-asserted-by":"publisher","first-page":"22484","DOI":"10.1074\/jbc.274.32.22484","volume":"274","author":"AV Kazansky","year":"1999","unstructured":"Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM . Differential effects of prolactin and src\/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem 1999; 274: 22484\u201322492.","journal-title":"J Biol Chem"},{"key":"BFonc2012369_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jcp.21112","volume":"213","author":"R Poincloux","year":"2007","unstructured":"Poincloux R, Cougoule C, Daubon T, Maridonneau-Parini I, Le Cabec V . Tyrosine-phosphorylated STAT5 accumulates on podosomes in Hck-transformed fibroblasts and chronic myeloid leukemia cells. J Cell Physiol 2007; 213: 212\u2013220.","journal-title":"J Cell Physiol"},{"key":"BFonc2012369_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1084\/jem.183.3.811","volume":"183","author":"N Carlesso","year":"1996","unstructured":"Carlesso N, Frank DA, Griffin JD . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl. J Exp Med 1996; 183: 811\u2013820.","journal-title":"J Exp Med"},{"key":"BFonc2012369_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2009-01-199307","volume":"114","author":"Y Shiotsu","year":"2009","unstructured":"Shiotsu Y, Kiyoi H, Ishikawa Y, Tanizaki R, Shimizu M, Umehara H et al. KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR\/ABL translocation. Blood 2009; 114: 1607\u20131617.","journal-title":"Blood"},{"key":"BFonc2012369_CR17","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1073\/pnas.122236099","volume":"99","author":"AP Costa-Pereira","year":"2002","unstructured":"Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is\u2019harc H et al. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci USA 2002; 99: 8043\u20138047.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012369_CR18","first-page":"3589","volume":"56","author":"S Danhauser-Riedl","year":"1996","unstructured":"Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M . Activation of Src kinases p53\/56lyn and p59hck by p210bcr\/abl in myeloid cells. Cancer Res 1996; 56: 3589\u20133596.","journal-title":"Cancer Res"},{"key":"BFonc2012369_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng1343","volume":"36","author":"Y Hu","year":"2004","unstructured":"Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 2004; 36: 453\u2013461.","journal-title":"Nat Genet"},{"key":"BFonc2012369_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.leukres.2007.11.032","volume":"32","author":"Y Ozawa","year":"2008","unstructured":"Ozawa Y, Williams AH, Estes ML, Matsushita N, Boschelli F, Jove R et al. Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leuk Res 2008; 32: 893\u2013903.","journal-title":"Leuk Res"},{"key":"BFonc2012369_CR21","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1074\/jbc.M209321200","volume":"278","author":"L Tatton","year":"2003","unstructured":"Tatton L, Morley GM, Chopra R, Khwaja A . The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J Biol Chem 2003; 278: 4847\u20134853.","journal-title":"J Biol Chem"},{"key":"BFonc2012369_CR22","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1038\/sj.onc.1204807","volume":"20","author":"Y Okutani","year":"2001","unstructured":"Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y et al. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 2001; 20: 6643\u20136650.","journal-title":"Oncogene"},{"key":"BFonc2012369_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/science.7541555","volume":"269","author":"CL Yu","year":"1995","unstructured":"Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995; 269: 81\u201383.","journal-title":"Science"},{"key":"BFonc2012369_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1749-6632.2010.05907.x","volume":"1217","author":"LM Heltemes-Harris","year":"2011","unstructured":"Heltemes-Harris LM, Willette MJ, Vang KB, Farrar MA . The role of STAT5 in the development, function, and transformation of B and T lymphocytes. Ann NY Acad Sci 2011; 1217: 18\u201331.","journal-title":"Ann NY Acad Sci"},{"key":"BFonc2012369_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2008.08.014","volume":"14","author":"N Kotecha","year":"2008","unstructured":"Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 2008; 14: 335\u2013343.","journal-title":"Cancer Cell"},{"key":"BFonc2012369_CR26","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.2353\/ajpath.2009.080953","volume":"175","author":"C Baumgartner","year":"2009","unstructured":"Baumgartner C, Cerny-Reiterer S, Sonneck K, Mayerhofer M, Gleixner KV, Fritz R et al. Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V. Am J Pathol 2009; 175: 2416\u20132429.","journal-title":"Am J Pathol"},{"key":"BFonc2012369_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/leu.2010.131","volume":"24","author":"G Li","year":"2010","unstructured":"Li G, Miskimen KL, Wang Z, Xie XY, Tse W, Gouilleux F et al. Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Leukemia 2010; 24: 1397\u20131405.","journal-title":"Leukemia"},{"key":"BFonc2012369_CR28","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1242\/jcs.03482","volume":"120","author":"A Herrmann","year":"2007","unstructured":"Herrmann A, Vogt M, M\u00f6nnigmann M, Clahsen T, Sommer U, Haan S et al. Nucleocytoplasmic shuttling of persistently activated STAT3. J Cell Sci 2007; 120: 3249\u20133261.","journal-title":"J Cell Sci"},{"key":"BFonc2012369_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1517\/14728222.9.2.329","volume":"9","author":"S Li","year":"2005","unstructured":"Li S . Src kinases as targets for B cell acute lymphoblastic leukaemia therapy. Expert Opin Ther Targets 2005; 9: 329\u2013341.","journal-title":"Expert Opin Ther Targets"},{"key":"BFonc2012369_CR30","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1182\/blood-2007-05-090969","volume":"110","author":"KD Bunting","year":"2007","unstructured":"Bunting KD, Xie XY, Warshawsky I, Hsi ED . Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD. Blood 2007; 110: 2775\u20132776.","journal-title":"Blood"},{"key":"BFonc2012369_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.molcel.2009.09.019","volume":"36","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Olsen JV, Brandts C, Cox J, Reddy PN, Bohmer FD et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 2009; 36: 326\u2013339.","journal-title":"Mol Cell"},{"key":"BFonc2012369_CR32","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1182\/blood-2007-10-121426","volume":"113","author":"D Schmidt-Arras","year":"2009","unstructured":"Schmidt-Arras D, Bohmer SA, Koch S, Muller JP, Blei L, Cornils H et al. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood 2009; 113: 3568\u20133576.","journal-title":"Blood"},{"key":"BFonc2012369_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1074\/jbc.271.2.695","volume":"271","author":"JH Hanke","year":"1996","unstructured":"Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996; 271: 695\u2013701.","journal-title":"J Biol Chem"},{"key":"BFonc2012369_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1074-5521(99)80118-5","volume":"6","author":"Y Liu","year":"1999","unstructured":"Liu Y, Bishop A, Witucki L, Kraybill B, Shimizu E, Tsien J et al. Structural basis for selective inhibition of Src family kinases by PP1. Chem Biol 1999; 6: 671\u2013678.","journal-title":"Chem Biol"},{"key":"BFonc2012369_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1182\/blood-2002-01-0288","volume":"101","author":"M Warmuth","year":"2003","unstructured":"Warmuth M, Simon N, Mitina O, Mathes R, Fabbro D, Manley PW et al. Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases. Blood 2003; 101: 664\u2013672.","journal-title":"Blood"},{"key":"BFonc2012369_CR36","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","volume":"21","author":"A Klejman","year":"2002","unstructured":"Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE et al. The Src family kinase Hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells. EMBO J 2002; 21: 5766\u20135774.","journal-title":"EMBO J"},{"key":"BFonc2012369_CR37","first-page":"104","volume":"1815","author":"G Ferbeyre","year":"2011","unstructured":"Ferbeyre G, Moriggl R . The role of Stat5 transcription factors as tumor suppressors or oncogenes. Biochim Biophys Acta 2011; 1815: 104\u2013114.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2012369_CR38","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1093\/emboj\/18.17.4754","volume":"18","author":"T Nosaka","year":"1999","unstructured":"Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL, Kitamura T . STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J 1999; 18: 4754\u20134765.","journal-title":"EMBO J"},{"key":"BFonc2012369_CR39","doi-asserted-by":"publisher","first-page":"e9152","DOI":"10.1371\/journal.pone.0009152","volume":"5","author":"G Li","year":"2010","unstructured":"Li G, Wang Z, Miskimen KL, Zhang Y, Tse W, Bunting KD . Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5. PLoS One 2010; 5: e9152.","journal-title":"PLoS One"},{"key":"BFonc2012369_CR40","first-page":"5348","volume":"57","author":"M Lilly","year":"1997","unstructured":"Lilly M, Kraft A . Enforced expression of the Mr 33\u2009000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Res 1997; 57: 5348\u20135355.","journal-title":"Cancer Res"},{"key":"BFonc2012369_CR41","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1038\/sj.onc.1202741","volume":"18","author":"M Lilly","year":"1999","unstructured":"Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A . The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999; 18: 4022\u20134031.","journal-title":"Oncogene"},{"key":"BFonc2012369_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1749-6632.2010.05192.x","volume":"1197","author":"FA Mallette","year":"2010","unstructured":"Mallette FA, Moiseeva O, Calabrese V, Mao B, Gaumont-Leclerc MF, Ferbeyre G . Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence. Ann NY Acad Sci 2010; 1197: 142\u2013151.","journal-title":"Ann NY Acad Sci"},{"key":"BFonc2012369_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1517\/13543784.2010.499898","volume":"19","author":"S Schenone","year":"2010","unstructured":"Schenone S, Brullo C, Musumeci F, Botta M . Novel dual Src\/Abl inhibitors for hematologic and solid malignancies. Expert Opin Investig Drugs 2010; 19: 931\u2013945.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFonc2012369_CR44","doi-asserted-by":"crossref","unstructured":"Ziegler P, Manz MG . Mouse models for human hemato-lymphopoiesis. Curr Protoc Toxicol 2007, Chapter 2: Unit2 13.","DOI":"10.1002\/0471140856.tx0213s31"},{"key":"BFonc2012369_CR45","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1242\/jcs.072520","volume":"124","author":"M Vogt","year":"2011","unstructured":"Vogt M, Domoszlai T, Kleshchanok D, Lehmann S, Schmitt A, Poli V et al. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3. J Cell Sci 2011; 124: 900\u2013909.","journal-title":"J Cell Sci"},{"key":"BFonc2012369_CR46","doi-asserted-by":"publisher","first-page":"30907","DOI":"10.1074\/jbc.M605902200","volume":"281","author":"MA Meyn","year":"2006","unstructured":"Meyn MA, Wilson MB, Abdi FA, Fahey N, Schiavone AP, Wu J et al. Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity. J Biol Chem 2006; 281: 30907\u201330916.","journal-title":"J Biol Chem"},{"key":"BFonc2012369_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.leu.2402778","volume":"17","author":"M Stanglmaier","year":"2003","unstructured":"Stanglmaier M, Warmuth M, Kleinlein I, Reis S, Hallek M . The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains. Leukemia 2003; 17: 283\u2013289.","journal-title":"Leukemia"},{"key":"BFonc2012369_CR48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/BJ20041523","volume":"390","author":"R Nyga","year":"2005","unstructured":"Nyga R, Pecquet C, Harir N, Gu H, Dhennin-Duthille I, Regnier A et al. Activated STAT5 proteins induce activation of the PI 3-kinase\/Akt and Ras\/MAPK pathways via the Gab2 scaffolding adapter. Biochem J 2005; 390: 359\u2013366.","journal-title":"Biochem J"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:13:28Z","timestamp":1647886408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,27]]},"references-count":48,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2013,8,1]]}},"alternative-id":["BFonc2012369"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.369","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,27]]},"assertion":[{"value":"13 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}